(MoneyNewsWire.Net, April 16, 2018 ) According to the report Multiple Myeloma Therapeutics, published by Market Data Forecast, the North America market is projected to reach USD 3.03 billion by 2022, at a CAGR of 4.37% from 2017 to 2022.
Various leading drugs are being produced in the market, most of them were approved in the past few years, and have improved median surviving rates by about fifty percent. The stem-cell relocation and advancement of drug therapy for treating myeloma and development of new agents has helped in raising the survival time for patients suffering from this disease.
Get a comprehensive overview of the North America Multiple Myeloma Therapeutics: https://www.marketdataforecast.com/market-reports/north-america-multiple-myeloma-therapeutics-market-859/
North America Multiple Myeloma Therapeutics: Drivers & Restraints
Multiple Myeloma Therapeutics market in this region is primarily driven by factors like rising demand for therapeutic products for managing blood diseases. This market is also being driven by factors such as rising incidence of disease cases, advancing additional treatments and continuous success of revlimid. However, the market is constrained due to factors such as stringent regulations by the government and side effects which are possible with the disease among others.
Get accurate market forecast and analysis on the North America Multiple Myeloma Therapeutics. Request a sample to stay up-to-date on the main trends affecting this market: https://www.marketdataforecast.com/market-reports/north-america-multiple-myeloma-therapeutics-market-859/request-sample
North America Multiple Myeloma Therapeutics: Segmentation
By Treatment Type
o Anthracycline antibiotic
o Alkylating agent
• Targeted Therapy
o Proteasome inhibitor
By Drug Type
o Dexamethasone (Decadron)
o Prednisone (Deltasone/Orasone)
• Immunomodulatory agents
o Thalidomide (Thalomid)
o Lenalidomide (Revlimid)
o Arsenic trioxide (Trisenox)
o Plerixafor (Mozobil)
• North America
o United States
From simple data collection through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at: https://www.marketdataforecast.com/market-reports/north-america-multiple-myeloma-therapeutics-market-859/customize-report
North America Multiple Myeloma Therapeutics: Overview
Factors such as growing incidence of disease cases and advancing additional therapies are affecting the growth of this market positively. However, other factors such as stringent regulations by the government are restraining the growth of this market. In this market, targeted therapy has the largest share which can be owed to its lesser side effects as compared to chemotherapy. Globally, North America region has the largest market for multiple myeloma therapeutics in the world by share. In the North America region, United States is expected to have the largest share and is also projected to grow at the fastest rate.
North America Multiple Myeloma Therapeutics: Key Players
Some of the major companies dominating North America Multiple Myeloma Therapeutics Market are MimiVax LLC, Terpenoid Therapeutics Inc., AB Science SA, Mirna Therapeutics, AbbVie Inc., Ablynx NV, RedHill Biopharma Ltd., Rhizen Pharmaceuticals S.A., Millennium Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Acceleron Pharma Inc., IGF Oncology LLC., ImmunGene Inc., TG Therapeutics Inc. and Johnson and Johnson.
Order your copy of the report: https://www.marketdataforecast.com/cart/buy-now/north-america-multiple-myeloma-therapeutics-market-859/
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
Follow us @ https://in.linkedin.com/company/market-data-forecast
Market Data Forecast.